Animal tumor models for PET in drug development

Area of Science:

• Preclinical research
• Oncology
• Medical imaging

Background:

• Positron emission tomography (PET) is crucial for evaluating anticancer agents in animal models.
• Selecting the right animal tumor model is essential for successful preclinical studies.
• There is a need for clear guidance on choosing suitable models for PET applications.

Purpose of the Study:

• To provide a comprehensive overview of animal tumor models for PET imaging.
• To guide investigators in selecting appropriate models for anticancer agent development.
• To introduce resources and principles for effective experimental design in preclinical oncology research.

Main Methods:

• Literature review of existing animal tumor models.
• Analysis of applicability of different models for PET imaging.
• Compilation of guiding principles for model selection.

Main Results:

• Identification of key factors for selecting animal tumor models for PET.
• Overview of various small animal models commonly used in oncology research.
• Discussion on the strengths and limitations of different models for PET-based efficacy studies.

Conclusions:

• Careful selection of animal tumor models is critical for the success of PET-based anticancer agent development.
• This review serves as a valuable resource for researchers designing preclinical PET studies.
• Utilizing appropriate models enhances the reliability and translatability of preclinical findings.